Table S1.
Immunization strategy | Number of mice | Serum titer of 2nd vaccinations | Serum titer of 3rd vaccinations | Rate of positive hybridoma | Amount of stable hybridoma |
---|---|---|---|---|---|
Subcutaneous | 1 | <1:103 | 1:104 | - | - |
2 | 1:104 | 1:105 | 9/146(0.062) | 2 | |
3 | <1:103 | <1:103 | - | - | |
4 | 1:104 | 1:106 | 12/136(0.089) | 2 | |
5 | <1:103 | <1:103 | - | - | |
Cytokine-assisted | 1 | 1:104 | 1:106 | - | - |
2 | 1:105 | 1:106 | 104/337(0.309) | 8 | |
3 | <1:103 | 1:104 | - | - | |
4 | <1:103 | 1:105 | - | - | |
5 | <1:103 | <1:103 | - | - |
Note: Serum titer was evaluated via CPP concentration of 1 µg mL−1 and absorbance above 0.3 at 450 nm. “ - ” represents mice that were not used in hybridoma preparation.